XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Aug. 03, 2024
STOCK-BASED COMPENSATION  
Schedule of options outstanding, vested or expected to vest, and exercisable

WEIGHTED

WEIGHTED

AGGREGATE

AVERAGE

AVERAGE

INTRINSIC

EXERCISE

REMAINING TERM

VALUE

SHARES

    

PRICE

    

(in years)

    

(in thousands)

Options outstanding

3,881,295

$

206.36

5.6

$

347

Options vested or expected to vest

3,503,891

$

199.66

5.3

$

341

Options exercisable

2,477,618

$

172.44

4.2

$

313

Schedule of stock-based compensation expense

THREE MONTHS ENDED

SIX MONTHS ENDED

AUGUST 3,

JULY 29,

AUGUST 3,

JULY 29,

    

2024

    

2023

    

2024

2023

(in thousands)

Stock-based compensation expense(1)

$

11,529

$

8,538

$

22,073

$

18,718

(1)On October 18, 2020, our Board of Directors granted Mr. Friedman an option to purchase 700,000 shares of our common stock with an exercise price equal to $385.30 per share under the Stock Incentive Plan. The option will result in aggregate non-cash stock compensation expense of $174 million. Amounts presented include $0.9 million and $2.0 million in the three months ended August 3, 2024 and July 29, 2023, respectively, and $2.8 million and $5.6 million in the six months ended August 3, 2024 and July 29, 2023, respectively, related to Mr. Friedman’s option.
Schedule of total unrecognized compensation expense and weighted average remaining term

UNRECOGNIZED

WEIGHTED

STOCK BASED

AVERAGE

COMPENSATION

REMAINING TERM

(in thousands)

(in years)

Unvested options(1)

$

141,217

5.2

Unvested restricted stock and restricted stock units

6,108

2.6

Total

$

147,325

(1)Excludes the remaining unrecognized compensation expense of $2.6 million related to the fully vested option grant made to Mr. Friedman in October 2020, which will be recognized on an accelerated basis through May 2025.